Stefanini, Bernardo http://orcid.org/0000-0003-3800-5678
Tovoli, Francesco
Trevisani, Franco
Marseglia, Mariarosaria
Di Costanzo, Giovan Giuseppe
Cabibbo, Giuseppe
Sacco, Rodolfo
Pellizzaro, Filippo
Pressiani, Tiziana
Chen, Rusi
Ponziani, Francesca Romana
Foschi, Francesco Giuseppe
Magini, Giulia
Granito, Alessandro
Piscaglia, Fabio
,
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
Article History
Received: 17 September 2023
Accepted: 5 March 2024
First Online: 29 March 2024
Declarations
:
: Francesco Tovoli has served as a consultant for Roche, Ipsen, and Eisai. Franco Trevisani is an advisor and a consultant for Bayer and Roche and an advisory board member for AstraZeneca, Bristol-Myers Squibb, and EISAI. Fabio Piscaglia is a consultant for AstraZeneca, Bayer AG, Bracco, and EISAI; Speaker bureau honoraria: Bayer AG, Bracco, EISAI, Laforce, MSD, Ipsen, Samsung, Siemens Healthineers, and Esaote. Alessandro Granito has served as a consultant for Bayer. All remaining authors have declared no conflicts of interest.